NICE指南:儿童和青年抑郁症鉴别与治疗

2019-10-01 国家卫生和护理研究所(NICE) NICE

本指南涵盖了识别和管理5至18岁儿童和年轻人的抑郁症。 它基于分步护理模型,旨在提高对轻度,中度至重度抑郁症的认识和评估,并促进有效的治疗。

中文标题:

NICE指南:儿童和青年抑郁症鉴别与治疗

英文标题:

Depression in children and young people: identification and management

发布日期:

2019-10-01

简要介绍:

本指南涵盖了识别和管理5至18岁儿童和年轻人的抑郁症。 它基于分步护理模型,旨在提高对轻度,中度至重度抑郁症的认识和评估,并促进有效的治疗。

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b07571c002058534, title=NICE指南:儿童和青年抑郁症鉴别与治疗, enTitle=Depression in children and young people: identification and management, guiderFrom=NICE, authorId=0, author=, summary=本指南涵盖了识别和管理5至18岁儿童和年轻人的抑郁症。 它基于分步护理模型,旨在提高对轻度,中度至重度抑郁症的认识和评估,并促进有效的治疗。, cover=, journalId=0, articlesId=null, associationId=1435, associationName=国家卫生和护理研究所(NICE), associationIntro=, copyright=0, guiderPublishedTime=Tue Oct 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">本指南涵盖了识别和管理5至18岁儿童和年轻人的抑郁症。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="1">它基于分步护理模型,旨在提高对轻度,中度至重度抑郁症的认识和评估,并促进有效的治疗。</span></span></p>, tagList=[TagDto(tagId=228, tagName=抑郁症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8746, appHits=529, showAppHits=0, pcHits=1586, showPcHits=8216, likes=3, shares=32, comments=45, approvalStatus=1, publishedTime=Mon Feb 15 22:55:30 CST 2021, publishedTimeString=2019-10-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sat Feb 13 20:24:01 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 17:26:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (37)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2211714, encodeId=34f82211e1441, content=点击此链接查看更多获取积分的方法或搜索关键词:积分查看https://www.medsci.cn/article/show_article.do?id=c629e679573f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/3e2aa1c3a6f246b5afa05a93ec2fefcd-lcGwS9MOWEjx.jpg, createdBy=3ede8538692, createdName=梅斯话题小助手, createdTime=Wed Jun 26 13:13:27 CST 2024, time=2024-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211693, encodeId=1c37221169368, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b18537175, createdName=ms6000001199547545, createdTime=Wed Jun 26 10:15:50 CST 2024, time=2024-06-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2024-06-26 梅斯话题小助手 来自上海

    点击此链接查看更多获取积分的方法或搜索关键词:积分查看https://www.medsci.cn/article/show_article.do?id=c629e679573f

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2211714, encodeId=34f82211e1441, content=点击此链接查看更多获取积分的方法或搜索关键词:积分查看https://www.medsci.cn/article/show_article.do?id=c629e679573f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/3e2aa1c3a6f246b5afa05a93ec2fefcd-lcGwS9MOWEjx.jpg, createdBy=3ede8538692, createdName=梅斯话题小助手, createdTime=Wed Jun 26 13:13:27 CST 2024, time=2024-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211693, encodeId=1c37221169368, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b18537175, createdName=ms6000001199547545, createdTime=Wed Jun 26 10:15:50 CST 2024, time=2024-06-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2023-02-03 ms5000000523501555 来自山西省

    积分

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2211714, encodeId=34f82211e1441, content=点击此链接查看更多获取积分的方法或搜索关键词:积分查看https://www.medsci.cn/article/show_article.do?id=c629e679573f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/3e2aa1c3a6f246b5afa05a93ec2fefcd-lcGwS9MOWEjx.jpg, createdBy=3ede8538692, createdName=梅斯话题小助手, createdTime=Wed Jun 26 13:13:27 CST 2024, time=2024-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211693, encodeId=1c37221169368, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b18537175, createdName=ms6000001199547545, createdTime=Wed Jun 26 10:15:50 CST 2024, time=2024-06-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2024-06-26 ms6000001199547545 来自江苏省

    积分

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2211714, encodeId=34f82211e1441, content=点击此链接查看更多获取积分的方法或搜索关键词:积分查看https://www.medsci.cn/article/show_article.do?id=c629e679573f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/3e2aa1c3a6f246b5afa05a93ec2fefcd-lcGwS9MOWEjx.jpg, createdBy=3ede8538692, createdName=梅斯话题小助手, createdTime=Wed Jun 26 13:13:27 CST 2024, time=2024-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211693, encodeId=1c37221169368, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b18537175, createdName=ms6000001199547545, createdTime=Wed Jun 26 10:15:50 CST 2024, time=2024-06-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2022-11-10 ozzy

    为了积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2211714, encodeId=34f82211e1441, content=点击此链接查看更多获取积分的方法或搜索关键词:积分查看https://www.medsci.cn/article/show_article.do?id=c629e679573f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/3e2aa1c3a6f246b5afa05a93ec2fefcd-lcGwS9MOWEjx.jpg, createdBy=3ede8538692, createdName=梅斯话题小助手, createdTime=Wed Jun 26 13:13:27 CST 2024, time=2024-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211693, encodeId=1c37221169368, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b18537175, createdName=ms6000001199547545, createdTime=Wed Jun 26 10:15:50 CST 2024, time=2024-06-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2022-05-18 122b0a30m85暂无昵称

    积分

    0